-
AZILECT 1 mg tablets
- admission: Great Britain
- Producer: Teva Pharma GmbH
- ATC-Code: N04BD02
-
Olanzapine Glenmark 10 mg tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark 15 mg tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark 2.5 mg tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark 20 mg tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark 5 mg tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark 7.5 mg tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark Europe 10 mg orodispersible tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark Europe 15 mg orodispersible tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark Europe 20 mg orodispersible tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Glenmark Europe 5 mg orodispersible tablets
- admission: Great Britain
- Producer: Glenmark Generics (Europe) Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Mylan 10 mg film-coated tablets
- admission: Great Britain
- Producer: Generics [UK] Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Mylan 15 mg film-coated tablets
- admission: Great Britain
- Producer: Generics [UK] Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Mylan 2.5 mg film-coated tablets
- admission: Great Britain
- Producer: Generics [UK] Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Mylan 20 mg film-coated tablets
- admission: Great Britain
- Producer: Generics [UK] Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Mylan 5 mg film-coated tablets
- admission: Great Britain
- Producer: Generics [UK] Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Mylan 7.5 mg film-coated tablets
- admission: Great Britain
- Producer: Generics [UK] Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Neopharma 10 mg coated tablets
- admission: Great Britain
- Producer: Neopharma Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Neopharma 15 mg coated tablets
- admission: Great Britain
- Producer: Neopharma Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Neopharma 2.5 mg coated tablets
- admission: Great Britain
- Producer: Neopharma Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Neopharma 5 mg coated tablets
- admission: Great Britain
- Producer: Neopharma Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Neopharma 7.5 mg coated tablets
- admission: Great Britain
- Producer: Neopharma Ltd.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Teva 10 mg film-coated tablets
- admission: Great Britain
- Producer: Teva Pharma B.V.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Teva 10 mg orodispersible tablets
- admission: Great Britain
- Producer: Teva Pharma B.V.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Teva 15 mg film-coated tablets
- admission: Great Britain
- Producer: Teva Pharma B.V.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine
-
Olanzapine Teva 15 mg orodispersible tablets
- admission: Great Britain
- Producer: Teva Pharma B.V.
- ATC-Code: N05AH03
- Therapeutic Area: Bipolar Disorder, Schizophrenia
- Active Substance: Olanzapine